{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-008984","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.717358+00:00","generated_at":"2026-05-28T23:17:21.928069+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Phio raises ~$0.48M in registered direct offering of 240K shares at $2.00/share with warrants","bullets":["Sold 240,000 shares of common stock at $2.00/share for gross proceeds of ~$0.48M; net ~$0.48M after expenses.","Issued warrants to purchase up to 240,000 additional shares at $2.00/share, exercisable immediately, expiring in 5 years.","H.C. Wainwright acted as placement agent; cash fees of 7.5% of gross proceeds plus management fee and warrants.","Proceeds to be used for working capital and general corporate purposes.","Closing occurred on Dec 24, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-008984","json":"https://secwatch.observer/filing/0001683168-24-008984.json","markdown":"https://secwatch.observer/filing/0001683168-24-008984.md","text":"https://secwatch.observer/filing/0001683168-24-008984.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824008984/0001683168-24-008984-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824008984/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:17:21.928069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}